---
figid: PMC3120937__WJG-17-2781-g002
figlink: /pmc/articles/PMC3120937/figure/F2/
number: Figure 2
caption: Drug inhibition of signalling pathways. Drugs that target signalling pathways
  can be divided into two groups. Antibodies [Becazutumab, trastuzumab, cetuximab
  and matuzumab are antibodies that target the receptor tyrosine kinase (RTK), vascular
  epidermal growth factor receptor (VEGFR), human epidermal growth factor receptor
  2 (HER2) and epidermal growth factor receptor 1 (EGFR) respectively] and small molecular
  inhibitors (The small molecular inhibitors gefitinib and erlotinib target EGFR.
  Temsirolimus specifically inhibits the PI3-kinase pathway at the level of Raptor/mTOR.
  CI1040 and PD0325901 inhibits ERK MAP kinase pathway at the level of MEK. Sorafenib
  is a dual inhibitor of the VEGF receptor and ERK MAP kinase at the level of RAF).
pmcid: PMC3120937
papertitle: 'Targeting key signalling pathways in oesophageal adenocarcinoma: A reality
  for personalised medicine?.'
reftext: Richard R Keld, et al. World J Gastroenterol. 2011 Jun 21;17(23):2781-2790.
pmc_ranked_result_index: '9926'
pathway_score: 0.9506567
filename: WJG-17-2781-g002.jpg
figtitle: Drug inhibition of signalling pathways
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3120937__WJG-17-2781-g002.html
  '@type': Dataset
  description: Drug inhibition of signalling pathways. Drugs that target signalling
    pathways can be divided into two groups. Antibodies [Becazutumab, trastuzumab,
    cetuximab and matuzumab are antibodies that target the receptor tyrosine kinase
    (RTK), vascular epidermal growth factor receptor (VEGFR), human epidermal growth
    factor receptor 2 (HER2) and epidermal growth factor receptor 1 (EGFR) respectively]
    and small molecular inhibitors (The small molecular inhibitors gefitinib and erlotinib
    target EGFR. Temsirolimus specifically inhibits the PI3-kinase pathway at the
    level of Raptor/mTOR. CI1040 and PD0325901 inhibits ERK MAP kinase pathway at
    the level of MEK. Sorafenib is a dual inhibitor of the VEGF receptor and ERK MAP
    kinase at the level of RAF).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - PIK3R6
  - WNT9A
  - WNT2B
  - PIK3CA
  - WNT11
  - WNT10B
  - MAPK9
  - MAP2K2
  - PIK3R3
  - MAPK12
  - WNT6
  - RAF1
  - WNT9B
  - ARAF
  - MAPK10
  - MAPK13
  - MAPK11
  - PIK3CB
  - PIK3CD
  - MAPK14
  - MAP2K1
  - WNT3
  - WNT5A
  - WNT16
  - WNT8A
  - EGFR
  - ERBB2
  - PIK3R5
  - PIK3R4
  - MAPK3
  - KDR
  - WNT2
  - WNT4
  - PIK3CG
  - WNT7B
  - WNT7A
  - WNT3A
  - WNT8B
  - RPTOR
  - BRAF
  - MAPK8
  - WNT1
  - FLT4
  - FLT1
  - WNT5B
  - MAPK1
  - WNT10A
  - Temsirolimus
  - PD0325901
  - Cancer
  - Lung cancer
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Raptor/
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: PD0325901
  source: MESH
  identifier: C506614
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
